Adjusting the price management mode of low-price drugs in Hunan

December 16th, 2016 | by

Hunan Development and Reform Commission recently published an announcement concerning drug prices. The announcement clarifies related policies about drug prices in Hunan medical institutions. According to the announcement, since the publication date of the announcement, sales without added profit should be implemented basing on the actual purchase price, when public medical institutions sell drugs (including secondary vaccine, excluding traditional Chinese medicine decoction pieces). For the sale of traditional Chinese medicine decoction pieces in public medical institutions, the added profit should not exceed 30 % on the basis of the cost price with tax (the wholesale price). The added profit of non-public medical institutions and social retail pharmacies can be formulated by institutions and pharmacies themselves. Drug prices should be shown to the public. (Source: Chinese Medicine News)


来源:中国医药报 2016-12-08


Leave a Reply

Your email address will not be published. Required fields are marked *